Thomas Geiser

10.4k total citations · 2 hit papers
195 papers, 6.4k citations indexed

About

Thomas Geiser is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Thomas Geiser has authored 195 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Pulmonary and Respiratory Medicine, 24 papers in Physiology and 23 papers in Molecular Biology. Recurrent topics in Thomas Geiser's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (55 papers), Neonatal Respiratory Health Research (27 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers). Thomas Geiser is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (55 papers), Neonatal Respiratory Health Research (27 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (22 papers). Thomas Geiser collaborates with scholars based in Switzerland, United States and Germany. Thomas Geiser's co-authors include Marco Baggiolini, Olivier T. Guenat, Michael A. Matthay, Ian Clark‐Lewis, Béatrice Dewald, Ralph A. Schmid, Bernhard Moser, Amiq Gazdhar, Markus U. Ehrengruber and Janick D. Stucki and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Thomas Geiser

173 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study

2021 265 citations Sabina A. Guler, Lukas Ebner et al. European Respiratory Journal profile →
Second-generation lung-on-a-chip with an array of stretchable alveoli made with a biological membrane

2021 230 citations Janick D. Stucki, Nina Hobi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Geiser Switzerland	41	2.3k	1.3k	1.2k	1.1k	1.0k	195	6.4k
Shaun P. Jackson Australia	61	2.2k 0.9×	1.4k 1.0×	3.0k 2.4×	582 0.5×	750 0.7×	156	11.3k
Christopher M. Waters United States	43	1.5k 0.7×	610 0.5×	2.2k 1.8×	531 0.5×	727 0.7×	135	5.8k
Erik Verbeken Belgium	41	2.4k 1.1×	784 0.6×	1.6k 1.3×	641 0.6×	1.0k 1.0×	157	7.3k
Mark R. Looney United States	40	1.9k 0.8×	2.4k 1.8×	1.5k 1.2×	394 0.4×	630 0.6×	97	6.9k
Mark Griffiths United Kingdom	36	2.9k 1.3×	783 0.6×	1.9k 1.6×	430 0.4×	505 0.5×	154	7.1k
Stewart J. Levine United States	41	808 0.4×	1.4k 1.0×	1.3k 1.1×	543 0.5×	473 0.5×	107	4.7k
Charles W. Frevert United States	44	2.3k 1.0×	2.4k 1.8×	1.7k 1.4×	367 0.3×	671 0.6×	120	6.5k
Rachel C. Chambers United Kingdom	49	4.1k 1.8×	975 0.7×	1.7k 1.4×	326 0.3×	491 0.5×	130	8.2k
Peter Wolf Austria	48	1.6k 0.7×	2.2k 1.6×	2.3k 1.9×	641 0.6×	981 0.9×	261	8.9k
Jahar Bhattacharya United States	45	3.1k 1.4×	1.2k 0.9×	2.8k 2.2×	634 0.6×	414 0.4×	122	7.6k

Countries citing papers authored by Thomas Geiser

Since Specialization

Citations

This map shows the geographic impact of Thomas Geiser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Geiser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Geiser more than expected).

Fields of papers citing papers by Thomas Geiser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Geiser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Geiser. The network helps show where Thomas Geiser may publish in the future.

Co-authorship network of co-authors of Thomas Geiser

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Geiser. A scholar is included among the top collaborators of Thomas Geiser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Geiser. Thomas Geiser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wang, Huijuan, Youssef Hibaoui, Anis Féki, et al.. (2024). Influence of Microenvironmental Orchestration on Multicellular Lung Alveolar Organoid Development from Human Induced Pluripotent Stem Cells. Stem Cell Reviews and Reports. 21(1). 254–275. 1 indexed citations

2.

Giezendanner, Stéphanie, Pierre‐Olivier Bridevaux, Prashant N. Chhajed, et al.. (2023). Risk Factors for Recurrent Exacerbations in the General-Practitioner-Based Swiss Chronic Obstructive Pulmonary Disease (COPD) Cohort. Journal of Clinical Medicine. 12(20). 6695–6695.

3.

Lenoir, Alexandra, Andreas Christe, Lukas Ebner, et al.. (2022). Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study. Respiration. 102(2). 120–133. 16 indexed citations

4.

Sengupta, Arunima, Nuria Roldán, Mirjam Kiener, et al.. (2022). A New Immortalized Human Alveolar Epithelial Cell Model to Study Lung Injury and Toxicity on a Breathing Lung-On-Chip System. SHILAP Revista de lepidopterología. 4. 840606–840606. 40 indexed citations

5.

Kiener, Mirjam, Nuria Roldán, Carlos Machahua, et al.. (2021). Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19. Frontiers in Medicine. 8. 644678–644678. 32 indexed citations

6.

Boesch, Maximilian, Florent Baty, Martin Brutsche, et al.. (2020). Transcriptomic profiling reveals disease-specific characteristics of epithelial cells in idiopathic pulmonary fibrosis. Respiratory Research. 21(1). 165–165. 9 indexed citations

7.

Schögler, Aline, Carmen Casaulta, Nicolas Regamey, et al.. (2015). Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection. Journal of Cystic Fibrosis. 15(3). 332–339. 25 indexed citations

8.

Bichsel, Colette A., Sean R. R. Hall, Ralph A. Schmid, Olivier T. Guenat, & Thomas Geiser. (2015). Primary Human Lung Pericytes Support and Stabilize In Vitro Perfusable Microvessels. Tissue Engineering Part A. 21(15-16). 2166–2176. 46 indexed citations

9.

Kocher, Gregor J., et al.. (2014). Pulmonary aspergilloma: A rare differential diagnosis to lung cancer after positive FDG PET scan. Respiratory Medicine Case Reports. 12. 1–3. 5 indexed citations

10.

Bucher, Christian H., Amiq Gazdhar, Lorin M. Benneker, Thomas Geiser, & Benjamin Gantenbein. (2013). Nonviral Gene Delivery of Growth and Differentiation Factor 5 to Human Mesenchymal Stem Cells Injected into a 3D Bovine Intervertebral Disc Organ Culture System. Stem Cells International. 2013. 1–9. 44 indexed citations

11.

Brill, Anne‐Kathrin, Alexander Kunz, Sebastian R. Ott, Thomas Geiser, & Jacqueline Pichler Hefti. (2012). When “High” Is not Very High: High Altitude Pulmonary Edema as First Manifestation of Sarcoidosis-Related Pulmonary Hypertension. High Altitude Medicine & Biology. 13(4). 285–287. 4 indexed citations

12.

Kieninger, Elisabeth, Marjolaine Vareille, Brigitte S. Kopf, et al.. (2011). Lack of an exaggerated inflammatory response on virus infection in cystic fibrosis. European Respiratory Journal. 39(2). 297–304. 30 indexed citations

13.

Geiser, Thomas, et al.. (2010). BVG und FZG : Bundesgesetze über die berufliche Alters-, Hinterlassenen- und Invalidenversicherung sowie über die Freizügigkeit in der beruflichen Alters-, Hinterlassenen- und Invalidenversicherung. IRIS. 1 indexed citations

14.

Geiser, Thomas, et al.. (2010). Das neue Erwachsenenschutzrecht. Alexandria (UniSG) (University of St.Gallen). 2 indexed citations

15.

Baltensperger, Urs, Josef Dommen, M. Rami Alfarra, et al.. (2008). Combined Determination of the Chemical Composition and of Health Effects of Secondary Organic Aerosols: The POLYSOA Project. Journal of Aerosol Medicine. 0(0). 2861233976–10. 7 indexed citations

16.

Baltensperger, Urs, Josef Dommen, M. Rami Alfarra, et al.. (2008). Combined Determination of the Chemical Composition and of Health Effects of Secondary Organic Aerosols: The POLYSOA Project. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 21(1). 145–154. 90 indexed citations

17.

Dorn, David, et al.. (2007). Die Berechnung des Erwerbsschadens. Alexandria (UniSG) (University of St.Gallen).

18.

Zhu, Sha, Lorraine B. Ware, Thomas Geiser, Michael A. Matthay, & Sadis Matalon. (2001). Increased Levels of Nitrate and Surfactant Protein a Nitration in the Pulmonary Edema Fluid of Patients with Acute Lung Injury. American Journal of Respiratory and Critical Care Medicine. 163(1). 166–172. 129 indexed citations

19.

Geiser, Thomas, Kamran Atabai, Pierre‐Henri Jarreau, et al.. (2001). Pulmonary Edema Fluid from Patients with Acute Lung Injury Augments In Vitro Alveolar Epithelial Repair by an IL-1 β -dependent Mechanism. American Journal of Respiratory and Critical Care Medicine. 163(6). 1384–1388. 136 indexed citations

20.

Geiser, Thomas, Barbara I. Kazmierczak, Lynne Garrity-Ryan, Michael A. Matthay, & Joanne N. Engel. (2001). Pseudomonas aeruginosa ExoT inhibits in vitro lung epithelial wound repair. Cellular Microbiology. 3(4). 223–236. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact